REGISTER
Dr. Giuseppe Curigliano at CSCO 2025
Growing evidence is reshaping how Dr. Giuseppe Curigliano at CSCO 2025 is understood. By organizing evidence on CSCO, MD, ADC, it turns scattered results into practical conclusions for clinicians and patients.

Giuseppe Curigliano, MD, Faculty of Medicine, University of Milan, Italy. ADC Drugs Revolutionizing Breast Cancer Therapy - Overcoming Resistance, Enhancing Combination Strategies, and Expanding Novel Targets to Advance Precision Medicine.

0
0
Loading